- Home
- ANVS vs HSPO Comparison
ANVS vs HSPO Comparison
Compare ANVS & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- HSPO
- Stock Information
- Founded
- ANVS 2008
- HSPO 2014
- Country
- ANVS United States
- HSPO United States
- Employees
- ANVS N/A
- HSPO N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- HSPO Blank Checks
- Sector
- ANVS Health Care
- HSPO Finance
- Exchange
- ANVS Nasdaq
- HSPO Nasdaq
- Market Cap
- ANVS 110.4M
- HSPO 87.7M
- IPO Year
- ANVS 2020
- HSPO 2022
- Fundamental
- Price
- ANVS $9.57
- HSPO $11.25
- Analyst Decision
- ANVS Strong Buy
- HSPO
- Analyst Count
- ANVS 6
- HSPO 0
- Target Price
- ANVS $29.67
- HSPO N/A
- AVG Volume (30 Days)
- ANVS 341.4K
- HSPO 27.4K
- Earning Date
- ANVS 11-06-2024
- HSPO 01-01-0001
- Dividend Yield
- ANVS N/A
- HSPO N/A
- EPS Growth
- ANVS N/A
- HSPO N/A
- EPS
- ANVS N/A
- HSPO 0.33
- Revenue
- ANVS N/A
- HSPO N/A
- Revenue This Year
- ANVS N/A
- HSPO N/A
- Revenue Next Year
- ANVS N/A
- HSPO N/A
- P/E Ratio
- ANVS N/A
- HSPO $34.26
- Revenue Growth
- ANVS N/A
- HSPO N/A
- 52 Week Low
- ANVS $4.53
- HSPO $10.60
- 52 Week High
- ANVS $22.49
- HSPO $11.25
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- HSPO 69.42
- Support Level
- ANVS $9.00
- HSPO $11.17
- Resistance Level
- ANVS $10.54
- HSPO $11.25
- Average True Range (ATR)
- ANVS 0.81
- HSPO 0.00
- MACD
- ANVS 0.12
- HSPO 0.00
- Stochastic Oscillator
- ANVS 74.57
- HSPO 100.00
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.